Cargando…

Reply to Comment on “Malfitano, A.M. et al. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532

Detalles Bibliográficos
Autores principales:	Malfitano, Anna Maria, Di Somma, Sarah, Prevete, Nella, Portella, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073196/ https://www.ncbi.nlm.nih.gov/pubmed/31979229 http://dx.doi.org/10.3390/cancers12020281

Ejemplares similares

Comment on: Malfitano, A.M. et al. “Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532
por: Alberts, Pēteris
Publicado: (2020)

Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
por: Malfitano, Anna Maria, et al.
Publicado: (2019)

Reply to Alberts, P. Comment on “Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525”
por: Hietanen, Eero, et al.
Publicado: (2022)

Reply to Comment by Young et al.
por: Mathews, F., et al.
Publicado: (2009)

Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
por: Kesić, Vesna, et al.
Publicado: (2022)

Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy
por: Di Somma, Sarah, et al.
Publicado: (2021)

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
por: Ramai, Daryl, et al.
Publicado: (2023)

Reply to the Comment of G. Feulner
por: Weber, Werner
Publicado: (2011)

Reply to the Comment by Littlechild and Isupov
por: Willetts, Andrew, et al.
Publicado: (2017)

Reply to Bracke et al. Comment on “Prayag et al. Light Modulation of Human Clocks, Wake, and Sleep. Clocks&Sleep 2019, 1, 193–208”
por: Prayag, Abhishek S., et al.
Publicado: (2021)

Reply to Dhawan et al. Comment on “Kim et al. The Association between Coffee Consumption and Risk of Colorectal Cancer in a Korean Population. Nutrients 2021, 13, 2753”
por: Kim, Youngyo, et al.
Publicado: (2021)

Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
por: Casiraghi, Antonella, et al.
Publicado: (2020)

Reply to Comment on “Jun, S.Y.; et al. Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma” Cancers 2020, 12, 2199
por: Jun, Sun-Young, et al.
Publicado: (2020)

Reply to the Comment Re: Magalhães-Sant’Ana, M. Animals 2019, 9, 168
por: Magalhães-Sant’Ana, Manuel
Publicado: (2020)

Reply to Comment on “Enumeration of Escherichia coli in Probiotic Products. Microorganisms 2019, 7, 437”
por: Zimmer, Camille, et al.
Publicado: (2020)

Reply to Comment on Roelofs, K.A.; et al. “Detecting Progression of Melanocytic Choroidal Tumours by Sequential Imaging: Is Ultrasonography Necessary?” Cancers 2020, 12, 1856
por: Roelofs, Kelsey A., et al.
Publicado: (2021)

Reply to Aguenaou et al. Comment on “Muzzioli et al. Are Front-of-Pack Labels a Health Policy Tool? Nutrients 2022, 14, 771”
por: Muzzioli, Luca, et al.
Publicado: (2022)

Reply to Vrijdag et al. Comment on “Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. Medicina 2021, 57, 1096”
por: Mankowska, Natalia D., et al.
Publicado: (2022)

Reply to Najjar, R.S. Comment on “Dyńka et al. The Ketogenic Diet and Cardiovascular Diseases. Nutrients 2023, 15, 3368”
por: Dyńka, Damian, et al.
Publicado: (2023)

Reply to Krupenko et al., Comment on “Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382”
por: Lee, Seon-Hyeong, et al.
Publicado: (2021)

Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”
por: Calfon-Peretz, Ortal, et al.
Publicado: (2022)

Reply to Zarguan et al. Comment on “Budryn et al. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies. Nutrients 2022, 14, 2476”
por: Grzelczyk, Joanna, et al.
Publicado: (2022)

Reply to the Comment on: Subrat Khanal et al. The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly. Biomedicines 2018, 6, 30
por: Khanal, Subrat, et al.
Publicado: (2019)

Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”
por: López-Yerena, Anallely, et al.
Publicado: (2020)

Reply to Chaudhuri et al. Comment on “Balwierz et al. Potential Carcinogens in Makeup Cosmetics. Int. J. Environ. Res. Public Health 2023, 20, 4780”
por: Balwierz, Radosław, et al.
Publicado: (2023)

Reply to Taylor et al. Comment on “Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443”
por: Manna, Antonio, et al.
Publicado: (2023)

Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
por: Macek Jilkova, Zuzana, et al.
Publicado: (2020)

Reply to the Comments on: Tian Zhao et al. The Principle of Least Action for Reversible Thermodynamic Processes and Cycles. Entropy 2018, 20, 542
por: Guo, Zeng-Yuan, et al.
Publicado: (2018)

Reply to Rourk, C. Comment on “Albantakis et al. Computing the Integrated Information of a Quantum Mechanism. Entropy 2023, 25, 449”
por: Albantakis, Larissa, et al.
Publicado: (2023)

Reply to Serrano et al. Comment on “Colletti et al. Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study. Cancers 2022, 14, 298”
por: Colletti, Gaia, et al.
Publicado: (2022)

Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Bellows, Steven, et al.
Publicado: (2020)

Reply to Campbell et al. Comment on “Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175”
por: Hogas, Mihai, et al.
Publicado: (2022)

Reply to Abenavoli et al. Comment on “Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687”
por: Clayton-Chubb, Daniel, et al.
Publicado: (2023)

Reply to Mankowska et al. Comment on “Muth et al. Assessing Critical Flicker Fusion Frequency: Which Confounders? A Narrative Review. Medicina 2023, 59, 800”
por: Muth, Thomas, et al.
Publicado: (2023)

Reply to Comments: “Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis” Int. J. Mol. Sci., 2019, 20, 4986
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Reply to Comment Clement et al.: (Prevalence of Antibodies against Hantaviruses in Serum and Saliva of Adults Living or Working on Farms in Yorkshire, United Kingdom)
por: Jameson, Lisa J., et al.
Publicado: (2014)

The Role of Historical Context in Understanding Past Climate, Pollution and Health Data in Trans‐disciplinary Studies: Reply to Comments on More et al., 2017
por: More, Alexander F., et al.
Publicado: (2018)

Reply to Nikolaidis, P.T.; Afonso, J. Comment on “Eschweiler et al. Anatomy, Biomechanics, and Loads of the Wrist Joint. Life 2022, 12, 188”
por: Eschweiler, Jörg, et al.
Publicado: (2022)

Comment on “Renail failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice” by Kawao et al. ‐ the authors' reply
por: Kawao, Naoyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e1lg9iidk6v8uuk3l88gc432af